Key regions: Australia, Italy, France, South Korea, Brazil
The demand for vaccines in Algeria has been on the rise in recent years, as the country has been experiencing an increase in the prevalence of infectious diseases.
Customer preferences: Algerian customers tend to prioritize vaccines that are effective against prevalent diseases such as tuberculosis, hepatitis, and meningitis. They also prefer vaccines that are affordable and easily accessible. Additionally, there is a growing demand for vaccines that have minimal side effects and are safe for children.
Trends in the market: One of the major trends in the Algerian vaccines market is the increasing adoption of combination vaccines, which provide protection against multiple diseases. This trend is driven by the convenience and cost-effectiveness of combination vaccines. Another trend is the growing use of vaccines for travel purposes, as more Algerians are traveling abroad for work or tourism. This has led to an increased demand for vaccines such as yellow fever and typhoid.
Local special circumstances: Algeria has a relatively high incidence of infectious diseases such as tuberculosis, hepatitis, and meningitis. This is due to factors such as poor sanitation, lack of access to clean water, and a high population density. Additionally, Algeria has a large population of migrant workers who may be more susceptible to certain diseases due to their living and working conditions.
Underlying macroeconomic factors: Algeria has a relatively stable economy, with a large oil and gas sector. However, the country has been facing economic challenges in recent years due to a decline in oil prices and political instability. This has led to a decrease in government spending on healthcare, which may impact the availability and affordability of vaccines. Additionally, Algeria has a relatively young population, which may drive demand for vaccines that are targeted at children and young adults.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
